We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+10.26%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$9.11B
AUM Growth
+$430M
Cap. Flow
-$417M
Cap. Flow %
-4.58%
Top 10 Hldgs %
48.86%
Holding
90
New
18
Increased
24
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$394M
2
META icon
Meta Platforms (Facebook)
META
+$345M
3
TWX
Time Warner Inc
TWX
+$345M
4
PLYA
Playa Hotels & Resorts
PLYA
+$311M
5
WAB icon
Wabtec
WAB
+$261M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$712M
2
CPAY icon
Corpay
CPAY
+$189M
3
CHTR icon
Charter Communications
CHTR
+$130M
4
BKNG icon
Booking.com
BKNG
+$110M
5
SSNC icon
SS&C Technologies
SSNC
+$109M

Sector Composition

Rank Sector Weight
1 Communication Services 22.15%
2 Technology 15.42%
3 Healthcare 15.15%
4 Industrials 8.86%
5 Consumer Staples 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLF icon
26
Herbalife
HLF
$1.33B
$122M 1.34%
4,198,406
– –
RDUS
27
DELISTED
Radius Health, Inc.
RDUS
$120M 1.32%
3,117,000
+987,000
+46% +$41.4M
LBTYK icon
28
Liberty Global Class C
LBTYK
$3.55B
$114M 1.25%
+3,249,122
New +$112M
LBTYA icon
29
Liberty Global Class A
LBTYA
$3.63B
$113M 1.24%
+3,147,585
New +$112M
MBLY
30
DELISTED
Mobileye N.V.
MBLY
$111M 1.22%
+1,810,000
New +$87M
ALR
31
DELISTED
Alere Inc
ALR
$108M 1.19%
2,730,500
+485,500
+22% +$18.9M
TMH
32
DELISTED
Team Health Holdings Inc
TMH
$102M 1.12%
2,298,900
-1,386,100
-38% -$60.2M
CPAY icon
33
Corpay
CPAY
$27.4B
$78.6M 0.86%
519,352
-1,203,087
-70% -$189M
EXEL icon
34
Exelixis
EXEL
$13.4B
$76.2M 0.84%
3,515,000
-950,000
-21% -$19.3M
TWX
35
PUT
DELISTED
Time Warner Inc
TWX
$55.7M 0.61%
570,000
– –
BKNG icon
36
Booking.com
BKNG
$158B
$43.7M 0.48%
614,275
-1,674,500
-73% -$110M
VEON icon
37
VEON
VEON
$4.09B
$42.6M 0.47%
417,377
+98,253
+31% +$10.1M
HUM icon
38
Humana
HUM
$45.5B
$40.9M 0.45%
198,500
-405,000
-67% -$83.7M
LOGM
39
DELISTED
LogMein, Inc.
LOGM
$39.5M 0.43%
+405,185
New +$40.3M
AZN icon
40
AstraZeneca
AZN
$257B
$35.9M 0.39%
576,250
+393,750
+216% +$22.9M
HZNP
41
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$35.4M 0.39%
2,395,000
+1,785,000
+293% +$28.9M
RC
42
Ready Capital
RC
$311M
$33.6M 0.37%
2,324,236
– –
H icon
43
Hyatt Hotels
H
$17B
$33.1M 0.36%
614,000
– –
SWC
44
DELISTED
Stillwater Mining Co
SWC
$31.3M 0.34%
+1,811,382
New +$31M
HW
45
DELISTED
Headwaters Inc
HW
$30.6M 0.34%
+1,305,000
New +$30.4M
VAL
46
DELISTED
Valspar
VAL
$30.5M 0.33%
+275,000
New +$30.2M
GWPH
47
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$30.2M 0.33%
250,000
+102,072
+69% +$12.5M
IMMU
48
DELISTED
Immunomedics Inc
IMMU
$26.9M 0.29%
+4,155,000
New +$21M
BMY icon
49
Bristol-Myers Squibb
BMY
$137B
$24.1M 0.26%
442,500
+132,500
+43% +$7.27M
PBYI icon
50
Puma Biotechnology
PBYI
$477M
$21.6M 0.24%
+580,500
New +$21.2M
1
2
3 4

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2017 Portfolio in Review

As of Q1 2017, Thomas Steyer held 90 positions worth $9.11B, up 5% from $8.68B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Thomas Steyer withdrew a net $417M in Q1 2017, closing 18 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $712M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Thomas Steyer opened a new position in Meta Platforms (Facebook) worth $367M.

  • Thomas Steyer's largest Q1 2017 buy was Meta Platforms (Facebook): 2,583,043 shares worth $367M.
  • Thomas Steyer added most to Yahoo Inc in Q1 2017, an estimated $394M increase.
  • Thomas Steyer's biggest Q1 2017 reduction was Corpay, cutting an estimated $189M.
  • Thomas Steyer fully exited St Jude Medical in Q1 2017, selling an estimated $712M.
  • Thomas Steyer's ten largest holdings make up 49% of its $9.11B portfolio in Q1 2017.
  • Thomas Steyer opened 18 new positions and closed 18 in Q1 2017.
  • Thomas Steyer's portfolio value rose 5% quarter-over-quarter to $9.11B.

Based on Farallon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.